Q4 2009

Source filing unavailable

Q4 2009 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived$47,044,000—

Free Cash Flowderived$35,757,000—

Same quarter

no prior Q4 2008 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR